Scientists have designed a new self-assembling nanoparticle
that targets tumours, to help doctors diagnose cancer earlier.
The new nanoparticle, developed by researchers at Imperial
College London, boosts the effectiveness of Magnetic Resonance Imaging (MRI)
scanning by specifically seeking out receptors that are found in cancerous
cells.